Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis
- PMID: 28179092
- DOI: 10.1016/j.dld.2017.01.142
Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis
Abstract
Background: Many studies have reported significant changes in intestinal microbiota in irritable bowel syndrome (IBS) patients based on quantitative real-time PCR analysis.
Aims: We aimed to review the alterations in intestinal microbiota.
Methods: An online search up to June 9, 2016, was conducted. This systematic review and meta-analysis included differential expression of intestinal microbiota in patients with IBS versus healthy controls (HCs) and subgroup analysis. We assessed the quality of the included studies using an original assessment tool.
Results: A total of 13 articles involving 360 IBS patients and 268 healthy controls were included. The quality assessment scores for these articles ranged from 5 to 8. Significant differences in expression in IBS patients were observed for Lactobacillus (SMD=-0.85, P<0.001, I2=28%), Bifidobacterium (SMD=-1.17, P<0.001, I2=79.3%), and Faecalibacterium prausnitzii (SMD=-1.05, P<0.001, I2=0.0%) but not Bacteroides-Prevotella group, Escherichia coli or other genera or species. Subgroup analysis showed that diarrhea-predominant IBS patients had significantly different expression of Lactobacillus (SMD=-1.81, P<0.001) and Bifidobacterium (SMD=-1.45, P<0.001).
Conclusion: Down-regulation of bacterial colonization including Lactobacillus, Bifidobacterium and F. prausnitzii was observed in IBS patients, particularly in diarrhea-predominant IBS (IBS-D). Microbiota changes participate in the pathogenesis of IBS and may underlie the efficacy of probiotic supplements.
Keywords: Intestinal microbiota; Irritable bowel syndrome; Meta-analysis; Systematic review.
Copyright © 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Identification of an intestinal microbiota signature associated with hospitalized patients with diarrhea.Acta Microbiol Immunol Hung. 2019 Jun 1;66(2):189-202. doi: 10.1556/030.66.2019.002. Epub 2019 May 7. Acta Microbiol Immunol Hung. 2019. PMID: 31062602
-
Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.Dig Dis Sci. 2018 Jul;63(7):1890-1899. doi: 10.1007/s10620-018-5086-4. Epub 2018 May 17. Dig Dis Sci. 2018. PMID: 29777439
-
The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.J Clin Gastroenterol. 2012 Mar;46(3):220-7. doi: 10.1097/MCG.0b013e31823712b1. J Clin Gastroenterol. 2012. PMID: 22157240 Clinical Trial.
-
Alterations of gut microbiota in patients with irritable bowel syndrome: A systematic review and meta-analysis.J Gastroenterol Hepatol. 2017 Jan;32(1):28-38. doi: 10.1111/jgh.13471. J Gastroenterol Hepatol. 2017. PMID: 27300149 Review.
-
Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.Postgrad Med. 2017 Nov;129(8):872-888. doi: 10.1080/00325481.2017.1383819. Epub 2017 Oct 13. Postgrad Med. 2017. PMID: 28936910 Review.
Cited by
-
A Systematic Review: Fecal Bacterial Profile in Patients with Irritable Bowel Syndrome Analyzed with the GA-Map Dysbiosis Test Based on the 16S rRNA Gene of Bacterial Species or Groups.Clin Exp Gastroenterol. 2024 Apr 17;17:109-120. doi: 10.2147/CEG.S451675. eCollection 2024. Clin Exp Gastroenterol. 2024. PMID: 38646157 Free PMC article. Review.
-
Blastocystis: A Mysterious Member of the Gut Microbiome.Microorganisms. 2024 Feb 24;12(3):461. doi: 10.3390/microorganisms12030461. Microorganisms. 2024. PMID: 38543512 Free PMC article. Review.
-
The Role of the FODMAP Diet in IBS.Nutrients. 2024 Jan 26;16(3):370. doi: 10.3390/nu16030370. Nutrients. 2024. PMID: 38337655 Free PMC article. Review.
-
Hydrogen Sulfide Producers Drive a Diarrhea-Like Phenotype and a Methane Producer Drives a Constipation-Like Phenotype in Animal Models.Dig Dis Sci. 2024 Feb;69(2):426-436. doi: 10.1007/s10620-023-08197-5. Epub 2023 Dec 7. Dig Dis Sci. 2024. PMID: 38060167 Free PMC article.
-
The gut microbiome dysbiosis and regulation by fecal microbiota transplantation: umbrella review.Front Microbiol. 2023 Nov 3;14:1286429. doi: 10.3389/fmicb.2023.1286429. eCollection 2023. Front Microbiol. 2023. PMID: 38029189 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical